Onno van de Stolpe
Encyclopedia
Onno van de Stolpe is a Dutch
businessman and is currently the CEO of Galapagos, a drug discovery and development company.
in Wageningen
(the Netherlands).
in 1999 while he was Managing Director Genomics at Introgene (now Crucell). Prior to joining Introgene in 1998, he was Managing Director of Molecular Probes Europe. He established this European headquarters after joining Molecular Probes in the US. Previously, he worked for the Netherlands Foreign Investment Agency in California, where he was responsible for recruiting biotech and medical device companies to locate in the Netherlands. Mr. Van de Stolpe started his career as Manager Business Development at MOGEN in Leiden.
Netherlands
The Netherlands is a constituent country of the Kingdom of the Netherlands, located mainly in North-West Europe and with several islands in the Caribbean. Mainland Netherlands borders the North Sea to the north and west, Belgium to the south, and Germany to the east, and shares maritime borders...
businessman and is currently the CEO of Galapagos, a drug discovery and development company.
Education
He obtained an MSc degree from the Agricultural UniversityWageningen University
Wageningen University and Research Centre is a Dutch public university in Wageningen, The Netherlands. It consists of Wageningen University, the Van Hall-Larenstein School of Higher Professional Education, and the former agricultural research institutes of the Dutch Ministry of Agriculture...
in Wageningen
Wageningen
' is a municipality and a historical town in the central Netherlands, in the province of Gelderland. It is famous for Wageningen University, which specializes in life sciences. The city has 37,414 inhabitants , of which many thousands are students...
(the Netherlands).
Career
Mr. Van de Stolpe founded Galapagos NVGalapagos NV
Galapagos is a mid-size biotechnology company specialized in the discovery and development of small molecule and antibody therapies with novel modes-of-action. The Company is progressing one of the largest pipelines in biotech, with seven clinical and over 50 small molecule discovery/pre-clinical...
in 1999 while he was Managing Director Genomics at Introgene (now Crucell). Prior to joining Introgene in 1998, he was Managing Director of Molecular Probes Europe. He established this European headquarters after joining Molecular Probes in the US. Previously, he worked for the Netherlands Foreign Investment Agency in California, where he was responsible for recruiting biotech and medical device companies to locate in the Netherlands. Mr. Van de Stolpe started his career as Manager Business Development at MOGEN in Leiden.